SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-413212
Filing Date
2014-11-14
Accepted
2014-11-14 16:07:24
Documents
3
Period of Report
2014-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d821670d8k.htm 8-K 19240
2 EX-10.1 d821670dex101.htm EX-10.1 77921
3 GRAPHIC g821670g69x23.jpg GRAPHIC 191199
  Complete submission text file 0001193125-14-413212.txt   361850
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 141224090
SIC: 2834 Pharmaceutical Preparations